Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609

Watchlist Manager
Shanghai HeartCare Medical Technology Corp Ltd Logo
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Watchlist
Price: 21.4 HKD 1.66% Market Closed
Market Cap: 831.1m HKD
Have any thoughts about
Shanghai HeartCare Medical Technology Corp Ltd?
Write Note

Shanghai HeartCare Medical Technology Corp Ltd
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai HeartCare Medical Technology Corp Ltd
Accumulated Depreciation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Accumulated Depreciation
-ÂĄ203.8m
CAGR 3-Years
-40%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Accumulated Depreciation
-ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Accumulated Depreciation
-ÂĄ3B
CAGR 3-Years
-20%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Accumulated Depreciation
-ÂĄ362.2m
CAGR 3-Years
-36%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Accumulated Depreciation
-ÂĄ963.8m
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai HeartCare Medical Technology Corp Ltd
Glance View

Market Cap
831.1m HKD
Industry
Health Care

Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-08-20. The firm's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The firm's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The firm's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The firm distributes its products within the domestic market.

Intrinsic Value
34.56 HKD
Undervaluation 38%
Intrinsic Value
Price

See Also

Back to Top